DEBRA BLAIR: Open Payments
NPI 1568454973 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 93 payments from 14 companies in 2025. Trend: 2023 $2,231 · 2024 $1,558 · 2025 $1,660
Food & beverage: $1,464Education: $197
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $453 |
| ABBVIE INC. | 22 | $384 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $182 |
| Phathom Pharmaceuticals, Inc. | 5 | $134 |
| PFIZER INC. | 5 | $104 |
| Ardelyx, Inc. | 3 | $85 |
| Novo Nordisk Inc | 3 | $70 |
| Madrigal Pharmaceuticals | 3 | $69 |
| Lilly USA, LLC | 3 | $60 |
| GENZYME CORPORATION | 1 | $30 |
Products named: TREMFYA, LINZESS, VOQUEZNA, CREON, EOHILIA, ENTYVIO, IBSRELA, RINVOQ.
Industry payments across NY — which companies pay providers there.
